Patents by Inventor Diane Michele Ignar

Diane Michele Ignar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of levocabastine and fluticasone furoate for the treatment of inflammatory and/or allergic conditions
    Patent number: 9675624
    Abstract: The present invention relates to pharmaceutical formulations comprising an anti-inflammatory glucocorticoid compound of the androstane series and levocabastine, an H1 antagonist/anti-allergic, and also relates to therapeutic uses thereof, particularly for the treatment of inflammatory and allergic conditions, specifically rhinitis.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: June 13, 2017
    Assignee: Glaxo Group Limited
    Inventors: Diane Michele Ignar, Daren Scott Levin
  • COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS
    Publication number: 20150297614
    Abstract: The present invention relates to pharmaceutical formulations comprising an anti-inflammatory glucocorticoid compound of the androstane series and levocabastine, an H1 antagonist/anti-allergic, and also relates to therapeutic uses thereof, particularly for the treatment of inflammatory and allergic conditions, specifically rhinitis.
    Type: Application
    Filed: December 13, 2013
    Publication date: October 22, 2015
    Applicant: Glaxo Group Limited
    Inventors: Diane Michele Ignar, Daren Scott Levin
  • METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS
    Publication number: 20100113512
    Abstract: A method of treatment using pharmaceutical compositions containing novel antagonists or inverse agonists at opioid receptors for the treatment of binge eating disorder, anorexia nervosa, bulimia nervosa, excess drug or alcohol use, or eating disorder not otherwise specified.
    Type: Application
    Filed: October 29, 2009
    Publication date: May 6, 2010
    Inventor: DIANE MICHELE IGNAR
  • Method of screening for GPR40 ligands
    Patent number: 7241579
    Abstract: Methods of screening for ligands of the GPR40 receptor are provided, including methods utilizing fatty acid GPR40 ligands.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: July 10, 2007
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham P.L.C.
    Inventors: John Leon Andrews, Celia Patricia Briscoe, Diane Michele Ignar, Allison Isobel Muir, Howard Ray Sauls, Jr., Mohammad Tadayyon
  • Method of screening for gpr40 ligands
    Publication number: 20040137517
    Abstract: Methods of screening for ligands of the GPR40 receptor are provided, including methods utilizing fatty acid GPR40 ligands.
    Type: Application
    Filed: June 18, 2003
    Publication date: July 15, 2004
    Inventors: John Leon Andrews, Celia Patricia Briscoe, Diane Michele Ignar, Alison Isobel Muir, Howard Sauls, Mohammad Tadayyon
  • Cysteinyl leukotriene receptor 2 (cysl t2)
    Publication number: 20040023861
    Abstract: The present invention provides an isolated cysteinyl leukotriene receptor polypeptide comprising
    Type: Application
    Filed: August 1, 2002
    Publication date: February 5, 2004
    Inventors: Diane Joan Cousens, Filippo Volpe, Diane Michele Ignar
  • High throughput method for screening candidate compounds for biological activity
    Publication number: 20030219825
    Abstract: A method for screening candidate compounds for an ability to modulate the biological activity of a target. The method includes the steps of providing a substrate comprising a target and an indicator, the substrate adapted for receiving a plurality of candidate compounds; contacting the substrate with a plurality of candidate compound samples in a manner wherein an identity of each candidate compound can be determined and wherein the candidate compounds in the candidate compound samples interact with the target in the substrate; detecting a signal, the signal produced by the indicator upon interaction between the target and a candidate compound; and identifying a candidate compound as a modulator of the biological activity of the target based upon an amount of signal produced.
    Type: Application
    Filed: December 12, 2002
    Publication date: November 27, 2003
    Inventors: Jill Elaine Haizlip, Diane Michele Ignar, Channa K Jayawickreme, Holly Kay King, James Arthur Liacos, Kirsten Mills, Jason J Ruan, Howard Ray Sauls Jr, Joel Edward Shaffer
  • Association of asthma with polymorphisms in the cysteinyl leukotriene 2 receptor
    Publication number: 20030203833
    Abstract: Polymorphisms in the cysteinyl-leukotriene receptor 2 gene and their association with asthma are described.
    Type: Application
    Filed: April 24, 2002
    Publication date: October 30, 2003
    Inventors: Diane Michele Ignar, Sreekumar Pillai
  • Novel Protein
    Publication number: 20030171545
    Abstract: A method for in a the identification of a compound which modulates leukotriene B4 like (LTRGW1) receptor activity comprises contacting an LTRGW1 polypeptide comprising) The amino acid sequence of SEQ ID #2, or ii) A variant of (i) which is capable of binding leukotrienes: or iii) A fragment of (i) or (ii) which is capable of binding leukotrienes. Additionally. LTRGW1 has been determined to enhance the response of the leukotriene B4 Receptor (BLTR) to LTB4. Hence LTRGW1 may be used in methods to indentify compounds which modulate BLTR receptor activity.
    Type: Application
    Filed: May 21, 2002
    Publication date: September 11, 2003
    Inventors: Diane Joan Cousens, Diane Michele Ignar, Philippe Sanseau, Filippo Volpe
  • Polypeptide
    Publication number: 20020137892
    Abstract: Isolated peptide transmitter-like receptor polypeptides, polynucleotides encoding such peptides, and methods of using such polypeptides in screening assays are described.
    Type: Application
    Filed: November 9, 2001
    Publication date: September 26, 2002
    Inventors: Steven M. Foord, Diane Michele Ignar
  • Polypeptide
    Publication number: 20020115205
    Abstract: The present invention provides an isolated receptor polypeptide having an immunomodulatory or neuromodulatory activity or endocrine function comprising:
    Type: Application
    Filed: October 18, 2001
    Publication date: August 22, 2002
    Inventors: Steven M. Foord, Diane Michele Ignar
  • Novel protein
    Publication number: 20020115102
    Abstract: A purinergic like polypeptide comprises
    Type: Application
    Filed: January 24, 2001
    Publication date: August 22, 2002
    Inventors: Diane Joan Cousens, Steven Michael Foord, Diane Michele Ignar, Filippo Volpe
  • Polypeptide
    Publication number: 20020065215
    Abstract: The present invention relates to an isolated P2Y-like receptor polypeptide, polynucleotides encoding the same and methods related thereto.
    Type: Application
    Filed: August 31, 2001
    Publication date: May 30, 2002
    Inventors: Steven M. Foord, Diane Michele Ignar
  • Association of asthma with polymorphisms in the cysteinyl leukotriene 2 receptor
    Patent number: H2153
    Abstract: Polymorphisms in the cysteinyl-leukotriene receptor 2 gene and their association with asthma are described.
    Type: Grant
    Filed: April 24, 2002
    Date of Patent: April 4, 2006
    Assignee: SmithKline Beecham Corp.
    Inventors: Diane Michele Ignar, Sreekumar Pillai